Life Sciences

Company Profile

Scioto Biosciences is a preclinical stage company developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics. The Scioto Platform has the potential to enhance efficacy wherever probiotics are used.

Scioto Biosciences in the News

Scioto Biosciences, Inc. Announces Top-Line Results of SB-121 in a Phase Ib Trial in Patients Diagnosed With Autism Spectrum Disorder
Scioto Biosciences, Inc. Announces First Patient Dosed in Phase Ib Study in Patients Diagnosed with Autistic Disorder
Nationwide Children’s Spinoff Fighting Infection in Premature Babies Raises $1.8M
Columbus Business First
Scioto Biosciences: Fortune Term Sheet — Tuesday, May 22
Fortune Term Sheet